Clinical Trials
3
Active:1
Completed:2
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion
Phase 3
Completed
- Conditions
- Parkinson's Disease
- First Posted Date
- 2006-12-07
- Last Posted Date
- 2012-03-07
- Lead Sponsor
- Axxonis Pharma AG
- Target Recruit Count
- 60
- Registration Number
- NCT00408915
- Locations
- 🇩🇪
Imerem GmbH, Nuremberg, Germany
Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
Phase 3
Completed
- Conditions
- Restless Legs Syndrome
- First Posted Date
- 2006-08-23
- Last Posted Date
- 2012-03-07
- Lead Sponsor
- Axxonis Pharma AG
- Target Recruit Count
- 300
- Registration Number
- NCT00367822
- Locations
- 🇩🇪
IMEREM GmbH, Nuremberg, Germany
News
No news found